Stay updated on HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Publications section now notes that listed publications are auto-filled from PubMed and may not pertain to the study. The footer revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedA government funding and operating status notice at the top of the page has been removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe new screenshot shows only minor visual/layout adjustments to the page without altering core study details. There are no additions or deletions to sections such as Study Overview, Eligibility Criteria, Interventions, or Outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedAdd: government-operating-status notice and v3.2.0; Remove: resource topic for Autoimmune thrombocytopenic purpura and v3.1.0.SummaryDifference5%

- Check78 days agoChange DetectedAdds Revision: v3.1.0 and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and Revision: v3.0.2; overall, updates versioning and trims older topics.SummaryDifference0.7%

- Check92 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing the previous v3.0.1. The 'Back to Top' element was removed.SummaryDifference0.3%

Stay in the know with updates to HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page.